Mobile

 Pharmacist's Letter
October Issue
 DEA's switch of all hydrocodone COMBOS (Vicodin, Tussionex, etc) to Schedule II on October 6 will cause lots of confusion
 Jardiance (jar-DEE-ans, empagliflozin) will be the third SGLT2 inhibitor
 All Current Issue topics...
 View September Issue

 Browse Categories
 Bone/Joint and Rheumatology
 Cardiology
 Dermatology
 Diabetes and Endocrinology
 More Categories...

Exit Mobile

Login  | Issues  | Feedback  | Search  | Browse  | New Drugs  | Email Us  | More >

[*]Top | [#]Bottom